Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single Arm Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of HL2351 in Patients With Cryopyrin Associated Periodic Syndromes

NCT02853084 is registered in ClinicalTrials.gov with Handok Inc. as lead sponsor.

NCT NCT02853084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single Arm Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of HL2351 in Patients With Cryopyrin Associated Periodic Syndromes
Lead sponsor
Handok Inc.
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2015
Completion date
January 31, 2019
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryopyrin-associated periodic syndromes (caps)